Author:
Trudeau Maureen,Charbonneau Flay,Gelmon Karen,Laing Kara,Latreille Jean,Mackey John,McLeod Deanna,Pritchard Kathy,Provencher Louise,Verma Shailendra
Reference44 articles.
1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005
2. Piccart M. Controversies in adjuvant systemic therapy for breast cancer. Educational session. Annual Meeting of the American Society of Clinical Oncology May 18–22, 2002; Orlando, FL, USA.
3. Adjuvant doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate and 5-fluorouracil chemotherapy in premenopausal women with axillary lymph node-positive breast carcinoma: results of a randomized controlled trial;Bang;Cancer,2000
4. Adjuvant chemotherapy of breast cancer with 4 cycles of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) versus 4 cycles of doxorubicin and cyclophosphamide (AC) in equitoxic regimen. The Comparative Muticentric Study;Pribylova;Proc Am Soc Clin Oncol,1999
5. Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.
Cited by
114 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献